Hong Kong’s listing overhaul: a bid to reclaim the biotech crown
For global biotech and life sciences firms weighing an IPO in Asia, Hong Kong’s willingness to rewrite its listing rules signals a serious effort to…
For global biotech and life sciences firms weighing an IPO in Asia, Hong Kong’s willingness to rewrite its listing rules…
For global biotech and life sciences firms weighing an IPO in Asia, Hong Kong’s willingness to rewrite its listing rules signals a serious effort to…
A quiet strategic shift is redefining global AI competition: the real prize may not be building the most powerful model, but deploying it at scale…
As world models emerge as the next critical layer for physical AI, China’s advantage is no longer theoretical. The country’s deep integration of AI development…
As the global race for a Covid-19 cure accelerates, China’s biotechnology sector is experiencing a powerful wave of consolidation and capital inflows, signalling a strategic…
For global professionals tracking China’s strategic technological ascent, the return of a leading researcher from the United States signals a deepening shift in the geography…
As the race for next-generation AI infrastructure intensifies, silicon photonics is emerging from the shadows. A Chinese pioneer’s push toward a public listing signals that…
For global professionals tracking the convergence of advanced manufacturing and artificial intelligence, Shanghai is no longer just the world’s car capital—it is the laboratory where…
For global pharmaceutical and tech investors, the convergence of deep-pocketed AI giants and drug discovery marks a pivotal shift in how new therapies may be…
Tighter US visa rules for highly-skilled foreign workers are steering top talent away from Silicon Valley and toward Chinese labs and firms, accelerating a quiet…
For global professionals tracking the energy transition, CATL’s move signals that securing raw materials—not just battery chemistry—is now the defining strategic challenge. The company is…